The Flowery: Comprehensive Company Profile
Background
Company Overview
The Flowery is a family-owned cannabis company headquartered in Homestead, Florida. Established in 2019, the company has rapidly expanded its operations, emphasizing high-quality cannabis cultivation and a commitment to community engagement. The Flowery operates under a vertically integrated model, managing every aspect of the cannabis process from seed to sale.
Mission and Vision
The Flowery's mission is to be the leading provider of the highest quality cannabis and brands in the state of Florida. The company aims to infuse creativity, innovation, and positivity into an exceptional brand grounded by the true culture of the industry and the Florida lifestyle. It seeks to form deep and lasting bonds with customers by treating them with respect and transparency, ultimately delivering an outstanding customer experience.
Key Strategic Focus
Core Objectives
- Quality Cultivation: Emphasizing superior indoor-grown cannabis through state-of-the-art facilities.
- Community Engagement: Building authentic relationships with consumers and local communities.
- Strategic Expansion: Extending operations into new markets, notably New York, while maintaining quality standards.
Areas of Specialization
- Premium Cannabis Products: Offering a diverse range of strains, edibles, vapes, and concentrates.
- Exclusive Partnerships: Collaborating with renowned brands like 710 Labs, Preferred Gardens, Doja, and Wizard Treez to bring sought-after strains and products to the market.
Key Technologies Utilized
- Advanced Cultivation Facilities: Operating a 100,000+ sq.ft. indoor facility designed to optimize plant growth conditions.
- Tech Integration: Utilizing tools such as Microsoft Clarity, Cloudflare CDN, and Zendesk to enhance operations and customer experience.
Primary Markets Targeted
- Florida: Established presence with multiple dispensaries and delivery services.
- New York: Recent expansion with locations in Staten Island, Queens, SoHo, and Brooklyn, aiming to set new standards in product quality and customer experience.
Financials and Funding
Revenue
As of November 2024, The Flowery's annual revenue reached approximately $35 million.
Funding History
Specific details regarding funding rounds and investors are not publicly disclosed. However, the company's significant expansion and facility investments indicate substantial financial backing.
Pipeline Development
Product Offerings
- Flower Strains: Including varieties like Neon Runtz, Lemon Cherry Gelato, and Blue Nerdz.
- Edibles: Such as 710 Labs Hash Rosin Chews.
- Concentrates: Including Persy Rosin Badder.
- Vaporizers: Live Resin Cartridges and All-In-One Vapes.
Upcoming Strains
The Flowery has announced an upcoming pipeline of flower varieties, including Bubblegum Marker, OG Marker, Cherry Sherbet, Candy Paint, Zello, and That's Krzy, all by Preferred Gardens.
Technological Platform and Innovation
Proprietary Technologies
- State-of-the-Art Cultivation Facility: A 100,000+ sq.ft. indoor facility designed to provide optimal conditions for cannabis growth.
Significant Scientific Methods
- Advanced Extraction Labs: Dedicated spaces for various extraction methods, including solventless extracts, in partnership with 710 Labs.
Leadership Team
Key Executives
- Elad Kohen: Founder and CEO. Kohen has been instrumental in shaping The Flowery's vision and expansion strategies, emphasizing quality and community engagement.
- Mike Smuts: Chief Operating Officer. Smuts brings extensive experience from previous roles in the cannabis industry, focusing on operational excellence and strategic growth.
- Matti Marshak: Director of Innovation. Marshak oversees product development and innovation, ensuring The Flowery remains at the forefront of cannabis offerings.
Leadership Changes
In recent years, The Flowery has expanded its leadership team by bringing on executives with significant industry experience, including those from One Plant, to bolster its growth and innovation capabilities.
Competitor Profile
Market Insights and Dynamics
The cannabis industry in Florida and New York is experiencing rapid growth, with increasing consumer demand and evolving regulatory landscapes. The market is characterized by a mix of large corporate entities and smaller, quality-focused operators like The Flowery.
Competitor Analysis
- Trulieve: A dominant player in Florida's cannabis market, known for its extensive dispensary network and product range.
- GrowHealthy: Another significant competitor in Florida, offering a variety of medical cannabis products and focusing on patient care.
- Curaleaf: A major multi-state operator with a presence in both Florida and New York, offering a wide range of cannabis products.
Strategic Collaborations and Partnerships
Notable Collaborations